Prostate-Specific Antigen (PSA) Testing Market Report

Global and China Prostate-Specific Antigen (PSA) Testing Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 28, 2022
  • PAGES：157
  • REPORT CODE：GMM1504232
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prostate-Specific Antigen (PSA) Testing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bristol-Myers Squibb Company

    • Medtronic

    • DiaSorin

    • Bayer AG

    • Mediwatch

    • GE Healthcare

    • Siemens Healthcare

    • PerkinElmer

    • Sanofi-Aventis SA

    • Endocare

    • Boston Scientific Corporation

    • Beckman Coulter

    • Ortho Clinical

    • Tosoh

    • Merck＆Co

    • Abbott

    • Roche

    • BodiTech

    • Fujirebio

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Chemiluminescence Immunoassay Method

    • Enzyme Linked Immunosorbent Assay Method

    Application:

    • Screening

    • Post-treatment Monitoring

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prostate-Specific Antigen (PSA) Testing Industry Overview

      • 1.1.1 Prostate-Specific Antigen (PSA) Testing Market Scope and Market Segments

      • 1.1.2 Prostate-Specific Antigen (PSA) Testing Industry Characteristics

      • 1.1.3 Global and China Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prostate-Specific Antigen (PSA) Testing Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Chemiluminescence Immunoassay Method

      • 1.2.2 Enzyme Linked Immunosorbent Assay Method

    • 1.3 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Screening

      • 1.3.2 Post-treatment Monitoring

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prostate-Specific Antigen (PSA) Testing Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prostate-Specific Antigen (PSA) Testing Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prostate-Specific Antigen (PSA) Testing Industry PEST Analysis

    • 2.3 Prostate-Specific Antigen (PSA) Testing Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prostate-Specific Antigen (PSA) Testing Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prostate-Specific Antigen (PSA) Testing Industry

    Chapter 3 Global and China Prostate-Specific Antigen (PSA) Testing Market, by Manufacturer

    • 3.1 Global and China Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prostate-Specific Antigen (PSA) Testing Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prostate-Specific Antigen (PSA) Testing Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prostate-Specific Antigen (PSA) Testing Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prostate-Specific Antigen (PSA) Testing Market Top 3 Players

    Chapter 4 Global and China Prostate-Specific Antigen (PSA) Testing Market, by Type (2017-2028)

    • 4.1 Prostate-Specific Antigen (PSA) Testing Market Trend, by Type

    • 4.2 Global Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prostate-Specific Antigen (PSA) Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prostate-Specific Antigen (PSA) Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prostate-Specific Antigen (PSA) Testing Price Trend, by Type (2017-2028)

    • 4.3 China Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prostate-Specific Antigen (PSA) Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prostate-Specific Antigen (PSA) Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prostate-Specific Antigen (PSA) Testing Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prostate-Specific Antigen (PSA) Testing Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prostate-Specific Antigen (PSA) Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prostate-Specific Antigen (PSA) Testing Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prostate-Specific Antigen (PSA) Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prostate-Specific Antigen (PSA) Testing Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prostate-Specific Antigen (PSA) Testing Market Analysis

    • 7.1 North America Prostate-Specific Antigen (PSA) Testing Market, by Type

    • 7.2 North America Prostate-Specific Antigen (PSA) Testing Market, by Application

    • 7.3 North America Prostate-Specific Antigen (PSA) Testing Market Analysis and Forecast, by Country

      • 7.3.1 United States Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prostate-Specific Antigen (PSA) Testing Market Analysis

    • 8.1 Europe Prostate-Specific Antigen (PSA) Testing Market, by Type

    • 8.2 Europe Prostate-Specific Antigen (PSA) Testing Market, by Application

    • 8.3 Europe Prostate-Specific Antigen (PSA) Testing Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prostate-Specific Antigen (PSA) Testing Market Analysis

    • 9.1 APAC Prostate-Specific Antigen (PSA) Testing Market, by Type

    • 9.2 APAC Prostate-Specific Antigen (PSA) Testing Market, by Application

    • 9.3 APAC Prostate-Specific Antigen (PSA) Testing Market Analysis and Forecast, by Country

      • 9.3.1 China Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Market Analysis

    • 10.1 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Market, by Type

    • 10.2 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Market, by Application

    • 10.3 Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prostate-Specific Antigen (PSA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prostate-Specific Antigen (PSA) Testing Company Profiles

      • 11.1 Bristol-Myers Squibb Company

        • 11.1.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bristol-Myers Squibb Company Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.1.3 Bristol-Myers Squibb Company Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Medtronic

        • 11.2.1 Medtronic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Medtronic Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.2.3 Medtronic Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 DiaSorin

        • 11.3.1 DiaSorin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 DiaSorin Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bayer AG

        • 11.4.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bayer AG Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.4.3 Bayer AG Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Mediwatch

        • 11.5.1 Mediwatch Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Mediwatch Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.5.3 Mediwatch Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GE Healthcare

        • 11.6.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GE Healthcare Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.6.3 GE Healthcare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Siemens Healthcare

        • 11.7.1 Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Siemens Healthcare Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.7.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 PerkinElmer

        • 11.8.1 PerkinElmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 PerkinElmer Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.8.3 PerkinElmer Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sanofi-Aventis SA

        • 11.9.1 Sanofi-Aventis SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sanofi-Aventis SA Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.9.3 Sanofi-Aventis SA Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Endocare

        • 11.10.1 Endocare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Endocare Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.10.3 Endocare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boston Scientific Corporation

        • 11.11.1 Boston Scientific Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boston Scientific Corporation Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.11.3 Boston Scientific Corporation Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Beckman Coulter

        • 11.12.1 Beckman Coulter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Beckman Coulter Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.12.3 Beckman Coulter Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Ortho Clinical

        • 11.13.1 Ortho Clinical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Ortho Clinical Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.13.3 Ortho Clinical Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Tosoh

        • 11.14.1 Tosoh Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Tosoh Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.14.3 Tosoh Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Merck＆Co

        • 11.15.1 Merck＆Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Merck＆Co Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.15.3 Merck＆Co Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Abbott

        • 11.16.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Abbott Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.16.3 Abbott Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Roche

        • 11.17.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Roche Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.17.3 Roche Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 BodiTech

        • 11.18.1 BodiTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 BodiTech Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.18.3 BodiTech Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Fujirebio

        • 11.19.1 Fujirebio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Fujirebio Prostate-Specific Antigen (PSA) Testing Product Profiles, Application and Specification

        • 11.19.3 Fujirebio Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prostate-Specific Antigen (PSA) Testing Industry Investment Prospect and Risk Assessment

    • 12.1 Prostate-Specific Antigen (PSA) Testing Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prostate-Specific Antigen (PSA) Testing Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Production Value and Growth Rate (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Production Value and Growth Rate (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Chemiluminescence Immunoassay Method (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Enzyme Linked Immunosorbent Assay Method (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Screening (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Post-treatment Monitoring (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prostate-Specific Antigen (PSA) Testing Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prostate-Specific Antigen (PSA) Testing Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prostate-Specific Antigen (PSA) Testing Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prostate-Specific Antigen (PSA) Testing Market Share, by Manufacturer in 2021

    • Figure Global and China Prostate-Specific Antigen (PSA) Testing Market Share, by Manufacturer in 2022

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Value, by Type (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Type (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Price Trend, by Type (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Value, by Type (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Type (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Price Trend, by Type (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Value, by Application (2017-2028)

    • Table Global Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Application (2017-2028)

    • Figure Global Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Application (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Value, by Application (2017-2028)

    • Table China Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Application (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Value Share, by Application (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export (2017-2022)

    • Table North America Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table North America Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure North America Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table North America Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table North America Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure North America Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure United States Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Table Europe Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table Europe Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Europe Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table Europe Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure UK Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure France Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure France Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Table APAC Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table APAC Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table APAC Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table APAC Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure India Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure India Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate-Specific Antigen (PSA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prostate-Specific Antigen (PSA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prostate-Specific Antigen (PSA) Testing Sales Value and Growth Rate (2017-2028)

    • Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Company Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Company Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medtronic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medtronic Product Profiles, Application and Specification

    • Table Medtronic Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table DiaSorin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table DiaSorin Product Profiles, Application and Specification

    • Table DiaSorin Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mediwatch Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mediwatch Product Profiles, Application and Specification

    • Table Mediwatch Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Product Profiles, Application and Specification

    • Table GE Healthcare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siemens Healthcare Product Profiles, Application and Specification

    • Table Siemens Healthcare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PerkinElmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PerkinElmer Product Profiles, Application and Specification

    • Table PerkinElmer Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi-Aventis SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi-Aventis SA Product Profiles, Application and Specification

    • Table Sanofi-Aventis SA Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Endocare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Endocare Product Profiles, Application and Specification

    • Table Endocare Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boston Scientific Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boston Scientific Corporation Product Profiles, Application and Specification

    • Table Boston Scientific Corporation Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beckman Coulter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beckman Coulter Product Profiles, Application and Specification

    • Table Beckman Coulter Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ortho Clinical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ortho Clinical Product Profiles, Application and Specification

    • Table Ortho Clinical Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tosoh Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tosoh Product Profiles, Application and Specification

    • Table Tosoh Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck＆Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck＆Co Product Profiles, Application and Specification

    • Table Merck＆Co Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BodiTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BodiTech Product Profiles, Application and Specification

    • Table BodiTech Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fujirebio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fujirebio Product Profiles, Application and Specification

    • Table Fujirebio Prostate-Specific Antigen (PSA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US